Our Clinical Staff

We've assembled one of the leading teams of MS specialists in the world right here at the RMMSC at CU. Each of our neurologists spends time treating patients, conducting research in their particular interest areas, and teaching the next generation of MS specialty physicians at the University of Colorado School of Medicine. For appointment information, please call the RMMSC at CU today at 720-848-2080 x. 4.

Dr. Jeffrey Bennett

Professor of Neurology and Ophthalmology,
CU School of Medicine, Department of Neurology

BennettDr. Bennett received his Biochemistry and Philosophy Degrees at Case Western Reserve University. He then received his medical and doctoral degrees at Stanford University. Dr. Bennett directs research programs on optic neuritis, demyelinating disorders, and ocular inflammatory diseases. He also maintains active specialty practices in neuro-ophthalmology, multiple sclerosis, neuromyelitis optica, and neuroimmunology.

As a clinician-scientist, Dr. Bennett is devoted to understanding the effects of autoimmune demyelination on the nervous system and using this knowledge to transform the care of affected individuals. In the clinic, Dr. Bennett directs clinical trials on new therapies for optic neuritis and neuromyelitis optica. In the laboratory, Dr. Bennett is working to identify the targets of the immune response in neuromyelitis optica and multiple sclerosis and is working to understand the mechanisms by which these disorders cause damage to the nervous system. His laboratory uses multiple experimental methods to evaluate the targets and action of antibodies derived from immune cells in the spinal fluid of neuromyelitis optica and multiple sclerosis patients, and employs state-of-the art techniques to establish the role of these antibodies in causing disease. Through his work, he has developed a novel antigen-specific therapy for neuromyelitis optica and is working towards similar goals in multiple sclerosis.

 

Dr. Teri Schreiner

Assitant Professor of Neurology,
CU School of Medicine, Department of Neurology

SchreinerDr. Schreiner has a masters degree in public health from Yale University and earned her medical degree from the University of Rochester in Rochester, N.Y. after working in healthcare consulting. Dr. Schreiner completed residency in Pediatric Neurology at the University of Colorado and Children’s Hospital Colorado. She currently sees pediatric neurology patients at Children’s Hospital Colorado, and sees both adults and children with neuroimmunologic disorders at the Rocky Mountain MS Center at University of Colorado. She is a past recipient of the National MS Society Clinical Fellowship Award.

Dr. Schreiner’s research interests include treatment and outcomes of pediatric onset multiple sclerosis. She is particularly interested in cognitive and psychosocial impact of pediatric diagnosis and environmental triggers of disease. She participates in many clinical trials of disease modifying therapies for MS, both adult and pediatric. She directs the Neuroimmunology Clinic for Children, a multidisciplinary clinic for the care of children and adolescents with MS. This clinic is staffed by a neuropsychologist, a psychologist, a social worker, Dr. Schreiner, a research coordinator and a pediatric neurology nurse.

Dr. Enrique Alvarez

Assistant Professor, CU School of Medicine, Department of Neurology

alvarezDr. Alvarez is a graduate of the Medical Scientist Training program at the University of Colorado Denver and completed his neurology residency and neuroimmunology fellowship at Washington University in St. Louis. He brings varied experience in MS and other neurological disorders to the Rocky Mountain MS Center at University of Colorado. He has a special interest in using biomarkers to customize treatments and patient care. He moved to the Denver area with his wife and two children. Most of his free time is spent with his family and his golden retriever, Daisy.

Dr. Alvarez’s research interests and projects include retrospective chart reviews, examining how patients have done in clinic outside of clinical trials to better understand how patients have done with their various treatments. He is also expanding the biorepository of cerebrospinal fluid and blood markers in order undertake biomarker studies. These biomarkers, which can also include MRI measures, will hopefully allow us to decide on the right treatment for each patient that will maximize their health with minimal risk.

Dr. Alvarez also provides regular MS specialty care to patients at Denver Health.